GGrantIndex
← Leaderboards

Christine M Finck

Drexel University

$4,232,950
Attributed
$6,320,169
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$6,320,169 · 5

By mechanism

R01$3,606,976 · 2
R44$1,826,710 · 1
R21$886,483 · 2

Top collaborators

Others in their field

Top investigators on “Cells

Research focus

CellsStem CellsCuesInnovationLungStructure Of Parenchyma Of LungChildhoodScaffoldLaboratoriesAlveolarEpithelial CellsEpithelialFutureBase3-DimensionalCell AdhesionIn VivoSurfactantEmbryoPremature BirthEmbryonic Stem CellPerinatal Mortality DemographicsEventTissue Engineering

Grant awards (16)

Ex vivo bioengineering of functional biomimetic airways for treatment of neonatal and pediatric respiratory conditions$247,743
R21 · FY2022 · HD · contact PI
Ex vivo bioengineering of functional biomimetic airways for treatment of neonatal and pediatric respiratory conditions$231,527
R21 · FY2021 · HD · contact PI
A retrievable autologous bioengineered esophageal implant as a novel treatment for long-gap esophageal atresia$498,749
R44 · FY2020 · HD
A retrievable autologous bioengineered esophageal implant as a novel treatment for long-gap esophageal atresia$1,103,346
R44 · FY2019 · HD
Immune Evasion in Embryonic Stem Cell-based Tissue Repair and Transplantation.$463,453
R01 · FY2018 · HL
A retrievable autologous bioengineered esophageal implant as a novel treatment for long-gap esophageal atresia$224,615
R44 · FY2018 · HD
Immune Evasion in Embryonic Stem Cell-based Tissue Repair and Transplantation.$463,453
R01 · FY2017 · HL
Immune Evasion in Embryonic Stem Cell-based Tissue Repair and Transplantation.$463,453
R01 · FY2016 · HL
Immune Evasion in Embryonic Stem Cell-based Tissue Repair and Transplantation.$478,099
R01 · FY2015 · HL
Optimal Derivation of Murine Embryonic Distal Airway Stem Cells$336,875
R01 · FY2014 · HL · contact PI
Optimal Derivation of Murine Embryonic Distal Airway Stem Cells$327,249
R01 · FY2013 · HL · contact PI
Optimal Derivation of Murine Embryonic Distal Airway Stem Cells$343,750
R01 · FY2012 · HL · contact PI
Optimal Derivation of Murine Embryonic Distal Airway Stem Cells$343,749
R01 · FY2011 · HL · contact PI
Optimal Derivation of Murine Embryonic Distal Airway Stem Cells$386,895
R01 · FY2010 · HL · contact PI
Biotechnology Based Fetal Pulmonary Tissue Engineering$219,713
R21 · FY2006 · EB · contact PI
Biotechnology Based Fetal Pulmonary Tissue Engineering$187,500
R21 · FY2005 · EB